NCT07054216招募中不适用
Efficacy of a Probiotic on Gut Health, Immune Maturation, and Well-being in Term Newborns - a Randomized, Double-blinded, Placebo-controlled Study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 378
- 试验地点
- 4
- 主要终点
- Total abundance of Bifidobacteria
研究概览
简要总结
The BABIES II study is a single-center, randomized, double-blinded, placebo-controlled study in newborns with an 8½ months intervention period from 14 days of age to 9 months of age followed by a 3-months short-term follow-up period until 1 year of age and a possible long-term follow-up until 18 years of age. The study will evaluate the effect of supplementation with a probiotic strain on different health outcomes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
盲法说明
Participant, Care Provider, Investigator, Outcomes Assessor
入排标准
- 年龄范围
- 0 Days 至 1 Day（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •"Inclusion Criteria"
- •Inclusion Criteria for the pregnant person
- •Pregnant person above 18 years of age in gestational week 36+0-38+0 (at Visit 0)
- •Singleton pregnancy
- •Ability to read and speak Danish
- •Plan to breastfeed
- •Provided voluntary written informed consent.
- •Inclusions Criteria for the newborn
- •Born at full-term ≥37+0
- •Birth weight ≥ 2500 g
- •APGAR score of ≥ 7 within the first 5 min of life.
排除标准
- •" Exclusion Criteria for the pregnant person
- •Pregnancy at 38 weeks + 0 or later at the time of recruitment
- •Pregnancy with significant fetal abnormality at ultrasound scan of the fetus at gestational age 19-20 weeks
- •Alcohol or drug abuse
- •Plan to give birth at other hospitals than Copenhagen University Hospital Hvidovre
- •Pregnant person with any contraindications for breastfeeding.
- •Exclusion Criteria for the newborn
- •Congenital disorders that could affect their safety or the study outcome
- •Admission to Neonatal Intensive Care Unit for more than 24 hours
- •Participation in another clinical intervention study which can interfere with this probiotic intervention
- •Probiotics other than the study product.
结局指标
主要结局
Total abundance of Bifidobacteria
时间窗: At 3 months of age
Abundance of Bifidobacteria in infant fecal samples by quantitative PCR
次要结局
- Infant fecal pH(Birth (first stool after meconium), 2 weeks, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 9 months, and 1 year)
- Infant gut microbiome composition(Birth (first stool after meconium), 2 weeks, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months, 9 months, and 1 year)
- Proportion of infants with hard or very hard stool consistency(4 months, 5 months, 6 months)
研究者
Andreas Munk Petersen
Professor Andreas Munk Petersen, MD, PhD, DMSc
Hvidovre University Hospital
研究点 (4)
Loading locations...
相似试验
招募中
不适用
Characterization of the Gastrointestinal Microbiota in Newborn InfantsNCT06789484Hvidovre University Hospital40
已完成
不适用
To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel SyndromeIrritable Bowel Syndrome With DiarrheaNCT04950296Vedic Lifesciences Pvt. Ltd.314
已完成
不适用
Safety and Tolerance Study of Three Probiotic Strains in InfantsBody WeightBody HeightHead CircumferenceNCT02215304ProbiSearch SL221
Unknown
不适用
Effects of Probiotics Supplementation on Intestinal Microbiome in Malignancy Pts(Get Pelvic/Abdominal Rtx)CancerNCT01706393Seoul National University Hospital26
已完成
不适用
Probiotic Intervention for Occasional ConstipationGut FunctionOccasional ConstipationNCT06444139Probi AB100